Related Experiment Video

Updated: Jul 28, 2025

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

977

Immature platelets and cardiovascular events in patients with stable coronary artery disease

Oliver Buchhave Pedersen1,2,3, Sanne Bøjet Larsen2, Steen Dalby Kristensen2,3

  • 1Thrombosis and Haemostasis Research Unit, Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.

Platelets
|May 29, 2023
PubMed

Insights

Immature platelet markers do not predict cardiovascular events in stable coronary artery disease (CAD) patients. This study found no link between immature platelets and future heart attacks or strokes in CAD individuals.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Platelet Biology

Background:

  • Aspirin resistance in coronary artery disease (CAD) patients may be linked to immature platelets.
  • Understanding predictors of cardiovascular events is crucial for patient management.

Purpose of the Study:

  • To investigate if immature platelet markers can predict cardiovascular events in stable CAD patients.
  • To assess the relationship between various immature platelet indices and adverse cardiovascular outcomes.

Main Methods:

  • A cohort of 900 stable CAD patients was followed for a median of 3 years.
  • Automated flow cytometry was used to measure immature platelet markers (e.g., immature platelet fraction, mean platelet volume).
  • Cardiovascular events (myocardial infarction, ischemic stroke, cardiovascular death) were tracked as primary and secondary endpoints.

Main Results:

  • No significant differences in immature platelet markers were observed between patients who experienced cardiovascular events and those who did not.
  • Hazard rate regression analysis indicated that immature platelet markers lacked predictive value for the studied endpoints (p > .05).
  • Immature platelet markers did not demonstrate predictive capability for future cardiovascular events over the 3-year follow-up period.

Conclusions:

  • Immature platelet markers do not appear to be major predictors of future cardiovascular events in stable CAD patients.
  • The role of immature platelets in the context of aspirin response or cardiovascular risk in stable CAD warrants further investigation.
  • These findings suggest that immature platelet measurements during a stable phase may not be clinically useful for risk stratification in CAD.

Keywords:
Coronary artery diseaseimmature plateletsischemic heart diseasepredictionreticulated platelets

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.1K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

524

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
570
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.7K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.3K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
16
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
773